sungran 300mg inj 1's
Highlights
- This medicine is indicated in bone marrow transplant patients or those who have received cytotoxic therapy to reduce the duration of neutropenia (decreased white blood cells) in them.
Description
SunGran 300mg inj 1's
- Sun-Gran 300mcg injection is composed of filgrastim (300mcg)
- Filgrastim is a granulocyte colony-stimulating factor (G-CSF) derivative derived from humans.
- It promotes the formation of white blood cells and tends to reduce the risk of infection in cancer patients receiving chemotherapy.
Directions For Use
- It is injected beneath the skin or into a vein depending on the filgrastim formulation.
- Use as instructed by your doctor often once day.
Warnings
- Filgrastim should only be used during pregnancy when absolutely necessary . Pregnant females should consult their doctors about the hazards and benefits of filgrastim.
- Filgrastim enters breast milk and can have adverse effects on a nursing baby. Lactating females should consult their doctor before using filgrastim.
- Filgrastim may have a minimal impact on driving abilities since after the administration of filgrastim dizziness can occur.
Precautions
- Because of the higher risk of splenic rupture filgrastim must be used cautiously. Patients who get stomach or shoulder tip pain when taking this medicine must consult their doctor right away. Based on the clinical situation your doctor may recommend you to discontinue Filgrastim.
- In rare situations filgrastim has been demonstrated to induce acute respiratory distress syndrome.
- Before taking any medicine evaluate the benefits and risks with your doctor. Priority should be given to reporting any fever or respiratory distress signs to a doctor. Depending on the clinical state replacement with an appropriate alternative may be required. Because of the higher risk of severe and life-threatening responses,
- Filgrastim is not advised for usage in patients with sickle cell disease history. Before taking any medicine, evaluate the benefits and risks with your doctor. Depending on the clinical state replacement with an appropriate alternative may be required.